(Q61956047)
Statements
A 52-Week, Open-Label, Long-Term Safety Study of LY2189265 in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus (English)
0 references
November 2011
0 references
December 2013
0 references
394
0 references
0 references
20 year
0 references